Braxia Scientific Corp.
BRAXF · OTC
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2020 FY | 212.00 | -8.95K | -172.47K | -172.72K | 0.00 |
| 2021 FY | 1.01M | -2.89M | -10.54M | -88.83M | -0.56 |
| 2022 FY | 1.49M | -3.28M | -7.16M | -12.13M | -0.07 |
| 2023 FY | 1.88M | 171.74K | -7.48M | -13.14M | -0.06 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2020 FY | 14.07M | 75.07K | 1.52M | 11.08K | 13.99M |
| 2021 FY | 18.49M | 2.60M | 11.10M | 107.56K | 15.89M |
| 2022 FY | 11.63M | 2.67M | 8.68M | 217.06K | 8.96M |
| 2023 FY | 3.88M | 2.28M | 1.46M | 207.16K | 1.60M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2020 FY | -288.83K | -60.00K | -348.83K | — | 855.67K |
| 2021 FY | -5.06M | -21.94K | -5.08M | — | 11.10M |
| 2022 FY | -4.52M | -25.21K | -4.54M | — | -2.42M |
| 2023 FY | -7.40M | -902.59K | -8.30M | — | -7.22M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2020 FY | 22.73M | 21.22M | — | — | — |
| 2021 FY | 75.25M | 64.25M | — | — | — |
| 2022 FY | 10.52M | 2.06M | — | — | — |
| 2023 FY | 5.90M | 4.64M | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2023 Q4 | 522.44K | -1.01M | -2.29M | -7.66M | -0.03 |
| 2024 Q1 | 600.20K | -133.45K | -789.52K | -802.25K | 0.00 |
| 2024 Q2 | 594.08K | 4.54K | -259.66K | -272.83K | 0.00 |
| 2024 Q3 | 492.45K | 81.98K | -977.13K | -907.05K | 0.00 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2023 Q4 | 3.88M | 2.28M | 1.46M | 207.16K | 1.60M |
| 2024 Q1 | 2.71M | 1.90M | 861.39K | 90.99K | 803.89K |
| 2024 Q2 | 2.91M | 2.38M | 709.68K | 546.32K | 535.16K |
| 2024 Q3 | 2.34M | 2.70M | 128.34K | 636.64K | -365.84K |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2023 Q4 | -1.32M | -31.95K | -1.35M | — | -30.28K |
| 2024 Q1 | -565.16K | -1.58K | -566.74K | — | -600.92K |
| 2024 Q2 | -141.52K | -0.74 | -141.52K | — | -151.71K |
| 2024 Q3 | -532.56K | -9.11K | -541.68K | — | -581.34K |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2023 Q4 | 6.81M | 5.55M | — | — | — |
| 2024 Q1 | 6.25M | 5.48M | — | — | — |
| 2024 Q2 | 3.58M | 3.42M | — | — | — |
| 2024 Q3 | 1.50M | 2.01M | — | — | — |